Vaginal diazepam plus transcutaneous electrical nerve stimulation to treat vestibulodynia: A randomized controlled trial



      To assess the effectiveness of vaginal diazepam in addition to transcutaneous electrical nerve stimulation (TENS) in the treatment of vestibulodynia (VBD).

      Study Design

      This study was a randomized, double-blind, placebo-controlled trial. Forty-two patients with VBD were randomized, 21 underwent diazepam and TENS (diazepam group) and 21 received placebo and TENS (placebo group). Vulvar pain was assessed on a on a 10-cm visual analogue scale (VAS) and dyspareunia according to the Marinoff dyspareunia scale. Vaginal surface electromyography (EMG) and vestibular current perception threshold (CPT) testing were performed at baseline and 60 days after treatment. The primary endpoints included the change in pain and dyspareunia from baseline to 60 days of pain and dyspareunia. The secondary endpoints was the variation in objectivity of pelvic floor muscle (PFM) function and vestibular nerve fiber current perception threshold (CPT).


      The VAS scores for pain from basal values of 7.5 and 7.2 for the diazepam and placebo, respectively, showed significant (p 0.01) decreases from 4.7 to 4.3, but this difference was not statistically significant. The Marinoff dyspareunia scores in the diazepam group showed a significant difference (p 0.05) from values measured in the placebo group. The ability to relax the PFM after contraction (difference between maximal contraction and rest tone) was significantly greater for the diazepam group versus the placebo group (3.8 μv and 2.4 μv, respectively, p 0.01). The CPT values for all of the nerve fibers increased after the treatment, but this increase was significant in the diazepam group only for the values at a 5-Hz stimulation (C fibers) with a change of 47.8% vs 26.9% (p < 0.05). Only two patients reported a mild drowsiness in the diazepam group.


      The present study provided indications that vaginal diazepam plus TENS is useful to improve pain and PFM instability in women with VBD.


      To read this article in full you will need to make a payment


        • Reed B.D.
        • Harlow S.D.
        • Sen A.
        • et al.
        Prevalence and demographic characteristics of vulvodynia in a population-based sample.
        Am J Obstet Gynecol. 2012; 206 (1-e9): 170
        • Harlow B.L.
        • Kunitz C.G.
        • Nguyen R.H.
        • Rydell S.A.
        • Turner R.M.
        • MacLehose R.F.
        Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions.
        Am J Obstet Gynecol. 2014; 210 (e1- e8): 40
        • Stockdale C.K.
        • Lawson H.W.
        2013 Vulvodynia guideline update.
        J Low Genit Tract Dis. 2014; 18: 93-100
        • Bornstein J.
        • Goldstein A.T.
        • Stockdale C.K.
        • Bergeron S.
        • Pukall C.
        • Zolnoun D.
        • et al.
        2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia.
        J Sex Med. 2016; 13: 607-612
        • Wesselmann U.
        • Bonham A.
        • Foster D.
        Vulvodynia: current state of the biological science.
        Pain. 2014; 155: 1696-1701
        • Gentilcore-Saulnier E.
        • McLean L.
        • Goldfinger C.
        • et al.
        Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program.
        J Sex Med. 2010; 7: 1003-1022
        • Goldstein A.T.
        • Pukall C.F.
        • Brown C.
        • Bergeron S.
        • Stein A.
        • Kellogg-Spadt S.
        Vulvodynia: assessment and treatment.
        J Sex Med. 2016; 13: 572-590
        • Polpeta N.C.
        • Giralgo P.C.
        • Teatin Juliato C.R.
        • Gomes Do Amaral R.L.
        • Moreno Linhares I.
        • Romero Leal Passos M.
        Clinical and therapeutic aspects of vulvodynia: the importance of physical therapy.
        Minerva Ginecol. 2012; 64437Y
        • Murina F.
        • Bianco V.
        • Radici G.
        • Felice R.
        • Di Martino M.
        • Nicolini U.
        Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomised controlled trial.
        BJOG. 2008; 115: 1165-1170
        • Murina F.
        • Graziottin A.
        • Felice R.
        • Radici G.
        • Tognocchi C.
        Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation.
        J Low Genit Tract Dis. 2013; 17: 111-116
        • Rogalski M.J.
        • Kellogg-Spadt S.
        • Hoffmann A.R.
        • et al.
        Retrospective chart review of vaginal diazepam suppository use in high tone pelvic floor dysfunction.
        Int Urogynecol J. 2010; 21: 895e9
        • Carrico D.J.
        • Peters K.M.
        Vaginal diazepam use with urogenital pain/pelvic floor dysfunction: serum diazepam levels and efficacy data.
        Urol Nurs. 2011; 31 (299)279e
        • Graziottin A.
        • Murina F.
        Vulvodynia tips and tricks.
        Springer, 2011
      1. Edwards L. ISSVD Vulvodynia Pattern Questionnaire. Availableat: Retrieved April 13, 2012.

        • Marinoff S.C.
        • Turner M.L.C.
        Vulvar vestibulitis syndrome.
        Dermatol Clin. 1992; 10435Y
        • Albrecht K.B.
        "How-To" Guide to pelvic floor muscle dysfunction.
        Clin Obstet Gynecol. 2015; 58: 546-550
        • Murina F.
        • Bianco V.
        • Radici G.
        • Felice R.
        • Signaroldi M.
        Electrodiagnostic functional sensory evaluation of patients with generalized vulvodynia: a pilot study.
        J Lower Gen Tract Dis. 2010; 14: 221Y4
        • Radbruch L.
        • Sabatowski R.
        • Elsner F.
        • Loick G.
        • Kohnen N.
        Patients’ associations with regard to analgesic drugs and their forms for application - a pilot study.
        Support Care Cancer. 2002; 10: 480-485
        • Gentilcore-Saulnier E.
        • McLean L.
        • Goldfinger C.
        • et al.
        Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program.
        J Sex Med. 2010; 7: 1003-1022
        • Glazer H.I.
        • Rodke G.
        • Swencionis C.
        • et al.
        Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature.
        J Reprod Med. 1995; 40: 283-290
        • White G.
        • Jantos M.
        • Glazer H.I.
        Establishing the diagnosis of vulvar vestibulitis.
        J Reprod Med. 1997; 45: 157-160
        • Vallinga M.S.
        • Spoelstra S.K.
        • Hemel I.L.M.
        • van de Wiel H.B.M.
        • Weijmar Schultz W.C.M.
        Transcutaneous electrical nerve stimulation as an additional treatment for women suffering from therapy-resistant provoked vestibulodynia: a feasibility study.
        J Sex Med. 2015; 12: 228-237
        • Sdrulla A.D.
        • Xu Q.
        • He S.Q.
        • Tiwari V.
        • Yang F.
        • Zhang C.
        • et al.
        Electrical stimulation of low-threshold afferent fibers induces a prolonged synaptic depression in lamina II dorsal horn neurons to high-threshold afferent inputs in mice.
        Pain. 2015; 156: 1008-1017
        • Cruccu G.
        • Azizc T.Z.
        • Garcia-Larreaa L.
        • Hanssona P.
        • Jensena T.S.
        • Lefaucheurg J.-P.
        • et al.
        EFNS guidelines on neurostimulation therapy for neuropathic pain.
        Eur J Neurol. 2007; 14: 952-970
        • Crisp C.C.
        • Vaccaro C.M.
        • Estanol M.V.
        • Oakley S.H.
        • Kleeman S.D.
        • Fellner A.N.
        • et al.
        Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial.
        Int Urogynecol J. 2013; 24: 1915-1923
        • Aalto A.P.
        • Vuoristo S.
        • Tuomaala H.
        • Niemi R.J.
        • Staff S.M.
        • Mäenpää J.U.
        Vulvodynia-younger age and combined therapies associate with significant reduction in self-reported pain.
        J Low Genit Tract Dis. 2017; 21: 209-214